• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

New Microbes New Infect . Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020

tetano

Editor, Senior Moderator
New Microbes New Infect


. 2021 Apr 24;100889.
doi: 10.1016/j.nmni.2021.100889. Online ahead of print.
Extensive genetic diversity with novel mutations in spike glycoprotein of SARS-CoV-2, Bangladesh in late 2020


Sultana Zahura Afrin[SUP] 1 [/SUP], Shyamal Kumar Paul[SUP] 2 [/SUP], Jahan Ara Begum[SUP] 3 [/SUP], Syeda Anjuman Nasreen[SUP] 1 [/SUP], Salma Ahmed[SUP] 1 [/SUP], Fahim Uddin Ahmad[SUP] 4 [/SUP], Md Abdul Aziz[SUP] 5 [/SUP], Rokshana Parvin[SUP] 3 [/SUP], Meiji Soe Aung[SUP] 6 [/SUP], Nobumichi Kobayashi[SUP] 6 [/SUP]



Affiliations

Abstract

In Bangladesh, COVID-19 has been highly prevalent during late 2020, causing nearly 500,000 confirmed cases. In the present study, spike (S) protein of severe acute respiratory coronavirus 2 (SARS-CoV-2) circulating in Bangladesh was genetically investigated to elucidate diversity of mutations and their prevalence. Nucleotide sequence of S protein gene was determined for 15 SARS-CoV-2 samples collected from 8 divisions in Bangladesh, and analyzed for mutations comparing with that of reference strain (hCoV-19/Wuhan/WIV04/2019). All the SARS-CoV-2 S genes were assigned to B.1 lineage in G clade, and individual S proteins had 1-25 mutations causing amino acid substitution/deletion. Total 133 mutations were detected in 15 samples, with G614D being present in all the samples, while 53 novel mutations as of Jan. 2021 were detected. On receptor-binding domain, 21 substitutions including ten novel mutations were identified. Other novel mutations were located on N-terminal domain (S1 subunit) and dispersed sites in S2 subunit, including two substitutions that remove potential N-glycosylation sites. P681R substitution adjacent to furin cleavage site was detected in one sample. All the mutations detected were located on positions that are functionally linked to host transition, antigenic drift, host surface receptor binding or antibody recognition sites, and viral oligomerization interfaces, which presumably related to viral transmission and pathogenic capacity.

Keywords: Bangladesh; Evolution; SARS-CoV-2; mutations; spike glycoprotein.
 
Back
Top Bottom